Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma

A relevant fraction of castration-resistant prostate cancers (CRPC) evolve into fatal neuroendocrine (NEPC) tumors in resistance to androgen deprivation and/or inhibitors of androgen receptor pathway. Therefore, effective drugs against both CRPC and NEPC are needed. We have previously described a du...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Sulsenti, Roberta, Frossi, Barbara, Bongiovanni, Lucia, Cancila, Valeria, Ostano, Paola, Fischetti, Irene, Enriquez, Claudia, Guana, Francesca, Chiorino, Giovanna, Tripodo, Claudio, Pucillo, Carlo E., Colombo, Mario P., Jachetti, Elena
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960782/
https://ncbi.nlm.nih.gov/pubmed/33737929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.622001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados